Page 27 - Co Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article SALT LAKE CITY, Feb. 23, 2021 /PRNewswire/ --  Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that it is pleased to welcome Brian Brown, CPA to the position of Co-Diagnostics Chief Financial Officer ("CFO"). Dr. Jesse Montgomery, PhD has also been elevated to the role of Chief Scientific Officer ("CSO"). Reed Benson, former CFO, will remain with the Company as general counsel, and Dr. Brent Satterfield, founder and former CSO, will continue his involvement with C...

Share this article SALT LAKE CITY, Feb. 16, 2021 /PRNewswire/ -- Co-Diagnostics, Inc.  (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that it will be presenting on direct saliva testing for COVID-19 at the 28 th Annual International Molecular Medicine Tri-Conference, held virtually on February 16-18, 2021. Company representatives will introduce the Co-Diagnostics Logix Smart SARS-CoV-2 DS (Direct Saliva) kit, which the Company has submitted for Emergency Use Authorization (EUA) to the US Food and Drug...